Nelson Watts, MD is Professor of Medicine at University of Cincinnati College of Medicine and Director of the University of Cincinnati Bone Health and Osteoporosis Center. He conducts research is in osteoporosis, particularly the study of therapeutic agents and tests for diagnosis and monitoring. He currently serves on the ABIM subspecialty board in Endocrinology and Metabolism, is Associate Editor of the Journal of Clinical Densitometry and is on the editorial boards of the Journal of Clinical Endocrinology and Metabolism, the Journal of Bone and Mineral Research and Osteoporosis International. He has served as President of the American College of Endocrinology, President of the International Society of Clinical Densitometry and Chair of the FDA’s Advisory Committee for Endocrine and Metabolic Drugs and is active in numerous professional organizations.
Disclosures:
Consulting: Amgen, Baxter, Eli Lilly, InteKrin, Johnson & Johnson, MannKind, Novartis, Novo Nordisk, Procter & Gamble, Sanofi-Aventis, Takeda Pharmaceuticals
Speaking/Teaching: Amgen, Novartis, Procter & Gamble, Sanofi-Aventis
Research: Amgen, Eli Lilly, Merck, Novartis, Ortho-McNeil Janssen, Procter & Gamble
|